Bed Bath & Beyond (BBBY) Tops Q3 EPS by 7c, Comps Decline 0.3%

(Updated - December 20, 2017 4:21 PM EST)

Bed Bath & Beyond (NASDAQ: BBBY) reported Q3 EPS of $0.44, $0.07 better than the analyst estimate of $0.37. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.9 billion.

Comparable sales in the fiscal 2017 third quarter decreased by approximately 0.3%.

Based upon its planning assumptions, the Company continues to model net earnings per diluted share for the full year to be about $3.00.

(Street sees FY EPS of $2.99)

For earnings history and earnings-related data on Bed Bath & Beyond (BBBY) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c
• Aeroflex Holdings (ARX) Tops Q2 EPS by 15c